Analysts Offer Predictions for NHI Q1 Earnings

National Health Investors, Inc. (NYSE:NHI) – Research analysts at Wedbush issued their Q1 2025 EPS estimates for National Health Investors in a note issued to investors on Monday, March 17th. Wedbush analyst R. Anderson anticipates that the real estate investment trust will earn $1.11 per share for the quarter. Wedbush has a “Outperform” rating and a $88.00 price target on the stock. The consensus estimate for National Health Investors’ current full-year earnings is $4.41 per share. Wedbush also issued estimates for National Health Investors’ Q2 2025 earnings at $1.16 EPS, Q3 2025 earnings at $1.18 EPS and Q4 2025 earnings at $1.21 EPS.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.03. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The company had revenue of $85.75 million during the quarter, compared to the consensus estimate of $81.13 million.

Separately, Truist Financial raised their target price on shares of National Health Investors from $70.00 to $76.00 and gave the company a “hold” rating in a research note on Wednesday. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, National Health Investors currently has an average rating of “Hold” and an average target price of $85.50.

National Health Investors Price Performance

NHI stock opened at $74.70 on Wednesday. National Health Investors has a 1 year low of $57.80 and a 1 year high of $86.13. The company has a market cap of $3.41 billion, a P/E ratio of 25.67, a PEG ratio of 4.42 and a beta of 1.08. The firm has a 50-day moving average of $70.22 and a 200 day moving average of $74.68. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29.

Institutional Investors Weigh In On National Health Investors

Institutional investors and hedge funds have recently made changes to their positions in the company. Quarry LP bought a new stake in shares of National Health Investors during the third quarter valued at approximately $27,000. Point72 DIFC Ltd bought a new stake in shares of National Health Investors during the third quarter valued at approximately $35,000. Loomis Sayles & Co. L P bought a new stake in shares of National Health Investors during the third quarter valued at approximately $38,000. Assetmark Inc. increased its position in shares of National Health Investors by 27.8% during the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock valued at $54,000 after acquiring an additional 141 shares in the last quarter. Finally, GF Fund Management CO. LTD. bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $58,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 2nd. Investors of record on Monday, March 31st will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 4.82%. The ex-dividend date is Monday, March 31st. National Health Investors’s dividend payout ratio (DPR) is currently 115.38%.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.